Price T Rowe Associates Inc Organogenesis Holdings Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 50,951 shares of ORGO stock, worth $145,719. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,951
Previous 50,951
-0.0%
Holding current value
$145,719
Previous $145,000
1.38%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ORGO
# of Institutions
120Shares Held
62.3MCall Options Held
28.8KPut Options Held
27.9K-
Morgan Stanley New York, NY11.6MShares$33.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT11.5MShares$32.9 Million3.27% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$14.5 Million0.0% of portfolio
-
Assenagon Asset Management S.A.3.98MShares$11.4 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$10.2 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $374M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...